We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ACB market cap is 299.28M. The company's latest EPS is CAD -0.4343 and P/E is -1.45.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 247.94M | 278.91M | 245.97M | 221.34M | 174.97M |
| Operating Income | -338.02M | -3.21B | -611.67M | -1.69B | -203.17M |
| Net Income | -293.51M | -3.28B | -693.63M | -1.72B | -206.3M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 5.5B | 2.78B | 2.6B | 1.08B | 926.32M |
| Total Liabilities | 1.11B | 656.7M | 567.03M | 422M | 409.19M |
| Total Equity | 4.39B | 2.12B | 2.04B | 662.35M | 517.14M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -192.25M | -342.14M | -210.58M | -109.84M | -115.82M |
| Investing | -312.3M | -245.43M | -26.91M | -36.6M | -27.29M |
| Financing | 597.55M | 582.56M | 521.95M | 147.78M | -71.41M |
| Market Cap | 299.28M |
| Price to Earnings Ratio | -1.45 |
| Price to Sales Ratio | 1.71 |
| Price to Cash Ratio | 1.27 |
| Price to Book Ratio | 0.58 |
| Dividend Yield | - |
| Shares Outstanding | 475.05M |
| Average Volume (1 week) | 761.72k |
| Average Volume (1 Month) | 1.05M |
| 52 Week Change | -63.79% |
| 52 Week High | 1.99 |
| 52 Week Low | 0.56 |
| Spread (Intraday) | 0.01 (1.56%) |
| Company Name | Aurora Cannabis Inc |
| Address |
1500 - 1055 west georgia street vancouver, british columbia V6E 4N7 |
| Website | https://www.auroramj.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
